Microbial Metabolites Inhibiting Salmonella Carriage and Disease
Project Number5R01AI172433-03
Former Number1R01DK133894-01
Contact PI/Project LeaderALTIER, CRAIG
Awardee OrganizationCORNELL UNIVERSITY
Description
Abstract Text
ABSTRACT
Diffusible signal factors (DSFs), long-chain fatty acids with a characteristic cis-2 unsaturation, are produced
and used by several genera of gram-negative bacteria as quorum-sensing signals. We have found that the
DSF cis-2 hexadecenoic acid (c2-HDA) is extremely potent in inhibiting expression of Salmonella functions
necessary for colonization of the intestine and have found this compound to be present in the murine large
intestine. As no mammalian source of fatty acids harboring a 2-cis unsaturation has been described, these
findings strongly suggest that constituents of the gut microbiota produce and excrete DSFs that inhibit
Salmonella virulence. We hypothesize that Salmonella uses the signals of these bacteria to balance its
virulence functions, essential but also costly to the fitness and survival of the invading bacteria, with
colonization and proliferation of the Salmonella population. Gut microbial metabolites may therefore serve
multiple coordinated purposes in pathogens, balancing virulence functions with those required for proliferation
within a host and thus affecting pathogen survival in the gut by multiple means. Here we propose to: Aim 1:
Use complementary approaches to identify bacteria of the human gut microbiome that produce inhibitory DSFs
and characterize their products; Aim 2: Identify the constellation of functions regulated in Salmonella by DSFs
and identify mechanisms of this control, and; Aim 3: Using established murine models of Salmonella infection,
characterize the biological function and translational relevance of c2-HDA to understand its mechanism of
action and to support the eventual development of novel therapeutics, such as live biotherapeutic products, for
the control of human salmonellosis.
Public Health Relevance Statement
PROJECT NARRATIVE
We have identified a class of microbial metabolites, present within the intestine, that potently represses
functions of Salmonella required for this pathogen to colonize and cause disease. We aim to identify the
bacterial sources of these signals within the gut microbiome and to characterize their global effects on
Salmonella virulence functions. This work is innovative and impactful as it investigates a novel means to
reduce the public health threat of salmonellosis.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
14-June-2022
Project End Date
31-May-2027
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$383,717
Direct Costs
$250,000
Indirect Costs
$133,717
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$383,717
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI172433-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI172433-03
Patents
No Patents information available for 5R01AI172433-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI172433-03
Clinical Studies
No Clinical Studies information available for 5R01AI172433-03
News and More
Related News Releases
No news release information available for 5R01AI172433-03
History
No Historical information available for 5R01AI172433-03
Similar Projects
No Similar Projects information available for 5R01AI172433-03